New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- New NJACTS Publication
- Scientists Find Why Ozempic Changes the Types of Food People Eat.
- Rutgers Physician Assistant Studies is Third in U.S. News and World Report’s Graduate School Rankings.
- Autism Rates Hit Record High, With One in 31 Children Affected, CDC Reports.
- How Much Do You Need to Walk to Offset the Harmful Effects of Sitting? Experts Explain.
Categories
- Community (2,261)
- Covid (986)
- CTO Events (6)
- News (2,881)
- Pilots (21)